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Table S2: Odds ratio and 95% confidence limits for cancers associated with variants with pleiotropic associations. Bold indicates risk allele.  
 
Region SNP† Gene Alleles EAF Cancer site GAME-ON Validation Combined 
      OR (95% CI) P-value OR (95% CI) P-value P-value 
1q22 rs1057941 MTX1 G/A 0.41 Breast 1.07 (1.04-1.11) 6.08 x 10
-5
 1.03 (1.01-1.05) 0.004 1.10 x 10
-5
 
     
Lung SqCC 1.10 (1.04-1.16) 0.001 1.12 (1.01-1.23) 0.03 1.21 x 10
-4
 
     
Aggressive prostate 1.09 (1.03-1.15) 0.004 --
 a
 --
 a
 --
 a
 
     
      
13q13.1 rs11571833 BRCA2 A/T 0.01 Serous ovarian 1.76 (1.30-2.39) 2.50 x 10
-4
 1.45 (1.22-1.72)  3.08 x 10
-5
 3.95 x 10
-8
 
     Lung (known) 1.91 (1.60-2.28) 1.23 x 10
-12
 --  
b
 -- 
 b
 --  
b
 
           
2q33.1 rs13016963 ALS2CR12 A/G 0.61 Prostate 1.08 (1.04-1.13) 3.05 x 10
-5
 1.05 (1.03-1.08) 7.62 x 10
-5
 1.90 x 10
-8
 
 rs1830298  T/C 0.29 Breast (known) 1.11 (1.07-1.15) 1.02 x 10
-7
 --  
b
 --  
b
 --  
b
 
           
9p21.3 
rs62560775 
CDKN2B-AS1 
A/G 0.09 
Lung 
Adenocarcinoma 
1.19 (1.08-1.31) 2.77 x 10
-4
 1.16 (1.03-1.30) 0.01 1.01 x 10
-5
 
 rs1011970  G/T 0.17 Prostate 1.10 (1.05-1.15) 7.29 x 10
-5
 1.05 (1.02-1.09) 0.001 9.51 x 10
-7
 
 
rs1333040 
 
T/C 0.43 
Lung 
Squamous cell 
(known) 
1.14 (1.08-1.20) 2.17 x 10
-6
 --  
b
 --  
b
 --  
b
 
           
aData not available; bpreviously known locus, thus did not include in the replication analysis.  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1: Flowchart showing analysis steps with first level showing initial logistic regression and meta-analysis to produce summary results for 
individual cancer sites, second level describing discovery analysis to find variants associated with subsets of cancers and the third level 
describing replication of specific variant cancer site associations from the identified subsets.  
  
Figure S2. Manhattan plots (-log10(p)) by chromosome for individual cancer sites (innermost to outermost ring – 
ovary(Ov) breast (Br), prostate (PR), colorectal/GECCO (Co), Lung (Lu)). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3. Results for rs11571833 (A) Forest plot showing per allele ORs for risk allele T of (T/A). Standard fixed 
effects meta-analysis (also indicated by dashed line), and subset meta-analysis results (two-sided, one-sided and 
positive and negative subset associations) are shown. (B) Regional plot showing two sided P values from ASSET 
subset meta-analysis at region 13q13.1 using GAME-ON/GECCO discovery set data. Peak is at BRCA2. rs11571815 
and rs11571818 (partially obscured by rs11571833) have nearly identical association signals. Abbreviations - CRC: 
colorectal, ERNEG: estrogen receptor negative, Aggrsv: aggressive, Adeno: Adenocarcinoma.  
 
 
 
  
 
 
A) Breast conditioned on ovary   B) Breast conditioned on prostate 
 
 
 
 
 
 
 
 
      C) Prostate conditioned on colorectal  D) Prostate conditioned on ovary   
 
 
 
 
 
 
 
 
Figure S4: Conditional QQ-plots. A through C provide evidence for pleiotropic association. Panel D  
(prostate and ovary) gives an example where no pleiotropic association is observed (no leftward 
deflection of the curve with deceasing p-value category of the conditioning cancer).   
 
